Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Maternal age \>/= 18~* Singleton gestation~* \>/=20 weeks gestation, \<37 weeks gestation~* Hemoglobin \<11g/dL and/or hematocrit \<33%~* Able to read/speak English or Spanish~Exclusion Criteria:~* Maternal age \<18~* Multiple gestation~* \<20 weeks gestation, \</= 37 weeks gestation~* Hemoglobin \>/=11g/dL and/or hematocrit \>/=33%~* Unable to read or speak English or Spanish~* Incarcerated patients

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Ferumoxyltol (Type: EXPERIMENTAL): Patients will receive two infusions of Ferumoxyltol, 510mg, intravenously, one week apart.~Iron studies will be completed at study inclusion and again at presentation for delivery. Cord blood will also be assessed for iron studies.
- Ferrous Sulfate (Type: ACTIVE_COMPARATOR): Patients will be provided with oral ferrous sulphate, 325mg, to take 2x daily at home.~Iron studies will be completed at study inclusion and again at presentation for delivery. Cord blood will also be assessed for iron studies.

Based on this trial design, predict the completion outcome and termination type (if applicable).